AIxCrypto Integrates Regulated Payments via BitMart Co-Branded Virtual Card, Expands Web3 Hub
- AIxCrypto is embedding its Web3 ecosystem into regulated payment rails to convert digital assets into real-world, compliance-aware payments.
- AIxCrypto partners with BitMart on a co-branded virtual prepaid card, acting as gateway while BitMart handles issuance and compliance.
- AIxCrypto reports 1.64M registered wallets, Season 2 upgrades, and AI-driven Web2-to-Web3 gateway features for broader user onboarding.
AIxCrypto moves payments closer to everyday use
AIxCrypto Inc. reports a strategic push to embed its Web3 ecosystem into regulated payment rails, signaling a move from experimental crypto utility toward mainstream payments and compliance-aware partnerships. The company says the step is aimed at converting community activity and digital assets into real-world user experiences while keeping regulated financial operations with licensed operators.
Co-branded virtual card deal positions AIxCrypto as gateway, not bank
AIxCrypto announces a partnership with BitMart to launch a co-branded virtual prepaid card program that targets eligible users across the AIxC ecosystem. Co-CEO Jerry Wang says AIxCrypto supplies community reach, brand participation and marketing support, while BitMart acts as the exclusive operator handling card issuance, user onboarding, compliance oversight, customer support and payment infrastructure subject to applicable regulatory and regional requirements.
The arrangement underscores AIxCrypto’s intent to separate product and community development from regulated financial functions, keeping operational control of payments with a licensed partner. Company messaging frames the deal as a way to provide “real-world utility” for token holders and ecosystem participants without exposing AIxCrypto to the licensing, compliance and consumer-facing obligations tied to issuing payments products.
Executives stress that the program forms part of a broader roadmap emphasizing scalable, compliant payment rails and AI-driven automation. Management positions the card as an integration point to bring users from Web2-style experiences into Web3 services, while minimizing legal and operational risk through clear contractual and functional boundaries.
Gaming season closed, platform upgrades roll out
AIxCrypto also concludes S1 Arena, the inaugural competitive season on AIxC Hub, and launches Season 2 as a platform upgrade. The company reports more than 1.64 million registered wallet addresses and over 7,200 registered teams, and says Season 2 transforms the Hub into a Web2-to-Web3 gateway powered by AI Agent infrastructure and integrated with its EAI‑RWA ecosystem, adding features like Tenki Stargaze and Fortune Collection.
Conference engagement drives institutional follow-ups
On the events front, AIxCrypto co-hosts a ConsensusHK 2026 panel titled “Beyond Scaling: AIxC and the Era of Autonomous DeFi,” and the company says it is turning conference momentum into institutional conversations. Management indicates the near-term roadmap prioritizes developer tooling, institutional outreach and converting partnerships and integrations into measurable user onboarding over coming quarters.
Related Cashu News

Bristol-Myers Squibb's Reclassification Enhances Growth Potential in Defensive Investment Strategy
Bristol-Myers Squibb Company (Ticker: BMY) undergoes a key reclassification across the Russell indexes, marking a transformative moment for the company. Moving to the Russell 1000 Defensive and Russel…

Vertex Pharmaceuticals' Casgevy Gains FDA Approval for Expanded Sickle Cell Disease Treatment Options
Vertex Pharmaceuticals (Ticker: VRTX) receives a significant boost in its ongoing battle against sickle cell disease with the recent FDA approval of an expanded label for its gene therapy product, Cas…

Gilead Sciences Gains FDA Approval for Trodelvy in First-Line Triple-Negative Breast Cancer Treatment
Gilead Sciences (Ticker: GILD) makes significant strides in oncology therapy with the recent approval of its drug Trodelvy for patients with unresectable or metastatic triple-negative breast cancer. T…

Merck Advances HIV Treatment and Faces Regulatory Scrutiny Amidst Market Success
Merck & Co. (Ticker: MRK) has recently made significant strides in the pharmaceutical landscape, particularly with its advancements in HIV treatment. The company's innovative drug, IDVYNSO, has receiv…